Amit Goyal, MD

DocwireNews

Advancements in mechanical circulatory support (MCS) devices for high-risk percutaneous coronary intervention (HR-PCI) have focused on achieving hemodynamic stability with minimal complications. The Impella device, a well-established transvalvular microaxial pump, is widely used and being actively investigated for supporting HR-PCI. Its use reduced all-cause mortality in patients with acute myocardial infarction-related cardiogenic shock, most of whom were treated with PCI, in the DanGer Shock trial. The cost was device-related complications, including more bleeding and limb ischemia in the Impella arm, emphasizing the need to develop safer mechanical circulatory support devices.
The Magenta Elevate is an innovative, expandable MCS device designed to address the limitations of traditional systems. It features a 9-Fr catheter-mounted microaxial pump that expands to 30-Fr within the left ventricle, providing high-output support. Delivered through a 10-Fr femoral introducer sheath, this device minimizes vascular trauma while offering flows up to 5.4 L/min. This expandable design allows for lower rotational speeds, potentially reducing hemolysis. In theory, this device is designed to provide adequate hemodynamic support with improved access-related safety profile and hemocompatibility.
The first-in-human study of the Magenta Elevate system, conducted by Schwammenthal et al., assessed its safety and efficacy in 14 patients undergoing HR-PCI, including interventions on unprotected left main coronary arteries. Device insertion, support, and removal were successful in all patients, although device malfunction in one required replacement with a new device. The device successfully maintained mean arterial pressure (MAP) and reduced left ventricular workload during a total of 20 prolonged left main balloon occlusions lasting an average of 39 +/- 16 seconds. MAP decreased by a median of only 7 mm Hg (7 mm Hg [13 to 2 mm Hg]; P &lt; 0.001), while diastolic aortic pressure increased (7 mm Hg [4 to 10 mm Hg]; P &lt; 0.0055), preserving myocardial perfusion. There were no hypotensive episodes and no need for vasoactive medications. There were no major device-related adverse events, and all patients survived to 30 days without significant complications.
Compared to existing devices like the Impella CP, which operates at higher rotational speeds and requires larger sheaths, the Magenta Elevate&#8217;s lower-profile delivery system is a meaningful advancement. Its ability to self-expand across the aortic valve enables robust hemodynamic support with slower rotational speeds to limit hemolysis and lower insertion profile to reduce access-related complications. Future studies are needed to confirm these findings in larger cohorts and explore the device&#8217;s application in cardiogenic shock and during more prolonged periods. For instance, the Impella CP’s larger 14-Fr access sheath allows single-access for PCI through the same access point, whereas the Magenta Elevate’s 10-Fr access requires a 2nd access point for PCI, which may counterbalance access-risks, particularly for patients in whom radial access is not an option.
Magenta Elevate system demonstrates a promising evolution in MCS technology, offering substantial cardiac support with reduced vascular complications. The investigational Impella ECP similarly provides LV-to-Aorta mechanical circulatory support through a 9-Fr access sheath utilizing an expandable flow pump. These innovative designs may expand the utility of MCS in interventional cardiology, ultimately improving outcomes for patients undergoing high-risk procedures.
References
Schwammenthal E, Gogorishvili I, Sievert H, Fefer P, Pinto DS. High-output mechanical circulatory support in left main interventions: the Magenta Elevate high-risk PCI first-in-human study. JACC Cardiovasc Interv. 2024;17(24):2851-2862. doi:10.1016/j.jcin.2024.09.017
Møller JE, Engstrøm T, Jensen LO, et al. Microaxial flow pump or standard care in infarct-related cardiogenic shock. N Engl J Med. 2024;390(15):1382-1393. doi:10.1056/NEJMoa2312572.

Rob Dillard

Are Mechanical Heart Valve Replacements Better for Long-Term Survival?

Interventional Cardiology

Jordana Jampel

ERCC1 Expression as Positive Biomarker for Adjuvant Chemo in TNBC

Breast Cancer News

Learn More About Hantavirus, the Infection that Killed Gene Hackman’s Wife

Infectious Disease

Latest News

Magenta Elevate: Redefining Mechanical Support for High-Risk PCI

Cardionerds is an entertaining and educational medical cardiology podcast created by three cardiologists. They want to bring high yield cardiovascular concepts in a fun and engaging format for their listeners of all levels. Click below to learn more!

CardioNerds

Dr. Amit Goyal details the first-in-human study of the Magenta Elevate system.

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

Mesothelioma

Non-Small Cell Lung Cancer

Small Cell Lung Cancer

Lung Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe